Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Tatva Chintan Pharma has made the recording of its earnings call, held on May 16, 2026, available on its company website. This provides investors access to the discussion and insights from the call.
May 16 2026 18:05:00
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem's Board recommended a final dividend of Rs.2 per equity share for the financial year 2025-26 in its meeting held on May 16, 2026. The record date will be intimated later.
May 16 2026 15:05:00
Tatva Chintan Pharma Chem Ltd - 543321 - Corporate Action-Board approves Dividend
Tatva Chintan Pharma Board recommended a final dividend of ₹2 per equity share for FY26. This 20% dividend on ₹10 face value is subject to shareholder approval at the AGM.
May 16 2026 15:05:00
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 16.05.2026
Tatva Chintan Pharma's Board approved Q4 FY26 cons. results with revenue of ₹134.14 cr and net profit of ₹10.32 cr. The company also recommended a ₹2 final dividend for FY26, subject to shareholder approval, and appointed new cost and internal auditors for FY26-27.
May 16 2026 15:05:00
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tatva Chintan Pharma Chem Limited will hold an earnings call on May 16, 2026, at 5:00 PM IST. The call is for discussing the financial results for the quarter and full financial year ended March 31, 2026, and will be hosted by ICICI Securities.
May 06 2026 18:05:00
Tatva Chintan Pharma Chem Ltd - 543321 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Tatva Chintan Pharma confirmed it is not classified as a Large Corporate as per SEBI circulars, meaning it is exempt from mandatory borrowing through debt securities. This clarifies its regulatory obligations concerning fund raising.
Apr 29 2026 11:04:00
Read More